Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2010 Apr;38(3):395-404.
doi: 10.1007/s10802-009-9373-6.

The relations among measurements of informant discrepancies within a multisite trial of treatments for childhood social phobia

Affiliations
Clinical Trial

The relations among measurements of informant discrepancies within a multisite trial of treatments for childhood social phobia

Andres De Los Reyes et al. J Abnorm Child Psychol. 2010 Apr.

Abstract

Discrepancies between informants' reports of children's behavior are robustly observed in clinical child research and have important implications for interpreting the outcomes of controlled treatment trials. However, little is known about the basic psychometric properties of these discrepancies. This study examined the relation between parent-child reporting discrepancies on measures of child social phobia symptoms, administered before and after treatment for social phobia. Participants included a clinic sample of 81 children (7-16 years old [M = 11.75, SD = 2.57]; 39 girls, 42 boys) and their parents receiving treatment as part of a multisite controlled trial. Pretreatment parent-child reporting discrepancies predicted parent-child discrepancies at posttreatment, and these relations were not better accounted for by the severity of the child's pretreatment primary diagnosis. Further, treatment responder status moderated this relation: Significant relations were identified for treatment non-responders and not for treatment responders. Overall, findings suggest that informant discrepancies can be reliably employed to measure individual differences over the course of controlled treatment trials. These data provide additional empirical support for recent work suggesting that informant discrepancies can meaningfully inform understanding of treatment response as well as variability in treatment outcomes.

Trial registration: ClinicalTrials.gov NCT00043537.

PubMed Disclaimer

References

    1. Psychol Bull. 2001 Sep;127(5):651-72 - PubMed
    1. Psychol Assess. 2004 Sep;16(3):330-4 - PubMed
    1. Psychol Bull. 2006 Jan;132(1):132-49 - PubMed
    1. J Autism Dev Disord. 2009 Aug;39(8):1163-72 - PubMed
    1. J Consult Clin Psychol. 2003 Feb;71(1):62-70 - PubMed

Publication types

MeSH terms

Substances

Associated data